Brugger W
Max Planck Society
3 Papers
83 Citations
Brugger W is an academic researcher from Max Planck Society. The author has contributed to research in topics: CD34 & Myeloid leukemia. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Brugger W include University of Tübingen & University of California, San Francisco.
Chat about Author
Papers
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.
Martina Seiffert,Charles Cant,Charles Cant,Charles Cant,Zhengjun Chen,Zhengjun Chen,Zhengjun Chen,Irene Rappold,Irene Rappold,Irene Rappold,Brugger W,Brugger W,Brugger W,Kanz L,Kanz L,Kanz L,Eric J. Brown,Eric J. Brown,Eric J. Brown,Axel Ullrich,Axel Ullrich,Axel Ullrich,Hans-Jörg Bühring,Hans-Jörg Bühring,Hans-Jörg Bühring +24 more
TL;DR: CD47 is identified as the extracellular ligand for human SIRP and it is shown that these two counterreceptors are involved in cellular adhesion.
311
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.
H J Bühring,Paul J. Simmons,M Pudney,Robert Müller,David Jarrossay,A van Agthoven,Martin Willheim,Brugger W,Peter Valent,Kanz L +9 more
TL;DR: The data show that the 97A6-reactive antigen plays a role in basophil activation and is expressed on multipotent CD34(+) progenitors, MC progenitor, Ba progensitors, as well as on mature Ba and tissue MC.
209
AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors.
TL;DR: In the hematopoietic system, AC133 expression is restricted to a subset of CD34+progenitor/stem cells and to leukemic blasts from patients with acute myeloid leukemia (AML).
86